Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 9.77
-0.35 (-3.46%)
Nov 13, 2026, 3:04 PM CST
SHE:002082 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 853.52 | 1,117 | 1,443 | 1,542 | 1,786 | 1,931 |
Revenue Growth | -38.44% | -22.59% | -6.39% | -13.69% | -7.47% | -85.91% |
Gross Profit Gross Profit Growth | 361.35 | 380.23 | 596.19 | 623.76 | 933.85 | 931.33 |
Operating Income Operating Income Growth | -125.92 | -139.38 | 76.65 | 70.19 | 232.58 | 210.69 |
Net Income Net Income Growth | -146.45 | -167.24 | 55.44 | 49.21 | 93.26 | 166.51 |
Earnings Per Share EPS Growth | -0.20 | -0.27 | 0.09 | 0.08 | 0.15 | 0.27 |
EPS Growth | - | - | 12.50% | -46.67% | -44.44% | -42.55% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Divison Pharmaceutical Divison Growth | 650.36 | 703.84 | 735.81 | 1,075 | 999.38 |
Medical Instruments Medical Instruments Growth | 466.97 | 464.92 | 494.65 | 407.64 | 456.56 |
Other Business Other Business Growth | - | 52.26 | 84.87 | 72.42 | 474.66 |
Medicine Circulation Medicine Circulation Growth | - | 222.35 | 226.62 | 231.3 | - |
Total Total Growth | 1,117 | 1,443 | 1,542 | 1,786 | 1,931 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 653.17 | 546.55 | 169.88 | 226.61 | 467.62 | 912.02 |
Total Debt Total Debt Growth | 993.8 | 1,115 | 1,028 | 975.84 | 864.42 | 842.48 |
Net Cash (Debt) Net Cash Growth | -340.64 | -568.4 | -858.34 | -749.23 | -396.8 | 69.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.46 | -0.92 | -1.39 | -1.22 | -0.64 | 0.11 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 699.05 | 603.98 | 120.22 | -72.87 | -239.65 | 22.09 |
Capital Expenditures CapEx Growth | 13.5 | -301.65 | -97.11 | -128.72 | -167.23 | -285.51 |
Free Cash Flow Free Cash Flow Growth | 712.55 | 302.33 | 23.11 | -201.59 | -406.88 | -263.42 |
Free Cash Flow Growth | - | 1208.10% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 42.34% | 34.03% | 41.30% | 40.45% | 52.28% | 48.24% |
Operating Margin | -14.75% | -12.47% | 5.31% | 4.55% | 13.02% | 10.91% |
Pretax Margin | -16.38% | -14.25% | 4.08% | 1.94% | 5.61% | 18.71% |
Profit Margin | -17.16% | -14.97% | 3.84% | 3.19% | 5.22% | 8.63% |
FCF Margin | 83.48% | 27.06% | 1.60% | -13.07% | -22.78% | -13.64% |
Fiscal Year | FY 2023 | FY 2022 |
|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.120 |
Dividend Per Share Growth | -33.33% | - |
Dividend Yield | 1.25% | 1.36% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 70.94 | 79.56 | 58.00 | 54.55 |
Forward PE | - | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
P/FCF Ratio | 8.39 | 28.18 | 170.18 | - | - | - |
PS Ratio | 7.00 | 7.63 | 2.73 | 2.54 | 3.03 | 4.70 |